Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation - Wikidata - awgldk - TriplyDB

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

http://www.wikidata.org/entity/Q28304239

about

MMP9 Rs3918242 Polymorphism Affects Tachycardia-Induced MMP9 Expression in Cultured Atrial-Derived Myocytes but Is Not a Risk Factor for Atrial Fibrillation among the Taiwanese The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation Potential Biological Markers of Atrial Fibrillation: A Chance to Prevent Cryptogenic Stroke Transcriptome profiling of cancer tissues in Chinese patients with gastric cancer by high-throughput sequencing.Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications.Matrix Metalloproteinase-9 Is a Predictive Factor for Systematic Hypertension and Heart Dysfunction in Patients with Obstructive Sleep Apnea Syndrome.Atrial Structural Remodeling Gene Variants in Patients with Atrial Fibrillation

P2860

Q36847087-887E4EA3-81A6-4021-A90D-282E3E9213E8 Q36920563-2056DA45-A594-4316-A086-FF74D50B2538 Q41146607-4D9D6202-559F-47F1-943A-91E0B2C42C0F Q50053646-2C86E416-5715-4C8B-8311-1533A1263FEC Q52340243-26DE8535-61CA-4C1A-8937-63AED507EB3C Q52564494-7E80FA5E-1B66-447A-A8CB-9E05D1339CF6 Q57114130-F832944B-A344-41C4-8396-838233D74F6C

P2860

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

http://www.wikidata.org/entity/Q28304239

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

@ast

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

@en

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

@nl

type

label

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

@ast

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

@en

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

@nl

prefLabel

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

@ast

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

@en

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

@nl

P1433

Q28304239-C3190320-AA7C-4C5F-ACC3-89CEEBB8296A

P1476

Q28304239-CA17E08F-7834-4C95-AD06-71C877983A24

P2093

Q28304239-1B9BA52C-46FE-47F1-A33E-96EBC7BEA800

Q28304239-5188C652-8B3F-440F-BEB1-C555679C4829

Q28304239-5A09D116-97E4-4DF5-967E-D0CD28A9C6EE

Q28304239-889C1B82-C72E-4CAF-BADB-AF8B1260DB81

Q28304239-E8FF3AB5-7AC8-4C26-85B3-AFA69B20FEE6

P2860

Q28304239-06278539-27F3-43C6-B94D-83FAE23D0E0A

Q28304239-075A6F1B-9E31-4CDF-83A3-0DB909719F3D

Q28304239-0FBE206C-9698-4A3C-8D6E-E0AD3A5CD26F

Q28304239-1F744EC2-09CF-45F9-9EB5-844C5F2A6C31

Q28304239-21D8D640-4BA6-4439-B674-7576BD5D1C1F

Q28304239-4C1C2F01-BC48-4643-96BE-23FF1F90A93A

Q28304239-538DF943-DC1A-4BFE-8BD4-E388164F2541

Q28304239-75D15C82-7E27-4B2E-8F1B-D3754903A4DC

Q28304239-830FBB08-0F3A-4531-8B14-7BBB4394E5D8

Q28304239-853BDE01-A2CE-4166-88FF-417F57322788

P304

Q28304239-D67B0148-6580-4741-A11E-6CB6F09E75EF

P31

Q28304239-2642AAB6-4AD4-4483-9B8E-A00F928B3512

P3181

Q28304239-D2CD0FE6-C9B4-40E1-A04C-22E41BFE6C6D

P356

Q28304239-498F0D36-4197-4FDC-9EB9-9B1D42114AFC

P407

Q28304239-5E5430AA-EB2B-4056-B411-0DCB16EBF1A6

P433

Q28304239-B52D1C8A-A56D-4AA1-94AA-786A0F9798C6

P478

Q28304239-5D2F238C-77B0-496E-9A31-B0E764D679E9

P577

Q28304239-A59B15E9-CCA8-45AF-A29B-4A5E225CF268

P5875

Q28304239-1F72035D-8E68-4078-BA18-42A9FD20F8A4

P698

Q28304239-995A43A0-7F00-453A-BB2E-1F9CF7664C6C

P921

Q28304239-6FF7A1F0-4F6A-4A37-92BF-5CE8FF8E5E64

P3181

P356

0300060513488514

P1433

Journal of International Medical Research

P1476

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation

@en

P2093

Bin Xie

http://www.w3.org/2001/XMLSchema#string

Congxin Huang

http://www.w3.org/2001/XMLSchema#string

Guokang Yang

http://www.w3.org/2001/XMLSchema#string

Kamesh Babu

http://www.w3.org/2001/XMLSchema#string

Mingjiang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction.

Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model.

Matrix metalloproteinases: regulation and dysregulation in the failing heart.

Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart.

Decreased metalloprotease 9 induction, cardiac fibrosis, and higher autophagy after pressure overload in mice lacking the transcriptional regulator p8.

Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes.

Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease.

Novel strategy to prevent atrial fibrosis and fibrillation.

P304

224-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1931754

http://www.w3.org/2001/XMLSchema#string

P356

10.1177/0300060513488514

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259351996

http://www.w3.org/2001/XMLSchema#string

P698

24345823

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation